Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial

BACKGROUND: Artemether–lumefantrine and artesunate–amodiaquine are used as first-line artemisinin-based combination therapies (ACTs) in west Africa. Pyronaridine–artesunate and dihydroartemisinin–piperaquine are potentially useful for diversification of ACTs in this region, but further safety and ef...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889791/
https://www.ncbi.nlm.nih.gov/pubmed/29606364
http://dx.doi.org/10.1016/S0140-6736(18)30291-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889791/
https://www.ncbi.nlm.nih.gov/pubmed/29606364
http://dx.doi.org/10.1016/S0140-6736(18)30291-5

Ejemplares similares